TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34952186

Group type: EXPERIMENTAL
Intervention: Tibial fixation of the ACL graft at 0° (n = 85)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Tibial fixation of the ACL graft at 30° (n = 84)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Tibial fixation at 0°
Number of subjects: 169

Group type: COMPARATOR
Intervention: Tibial fixation at 30°
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Both groups (0° and 30°)
Number of subjects: 169
Study: 34377158

Group type: EXPERIMENTAL
Intervention: Atezolizumab + Bevacizumab + Gemcitabine/Cisplatin (Gem/Cis)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Atezolizumab + Placebo + Gemcitabine/Cisplatin (Gem/Cis)
Number of subjects: 150
Study: 35909582

Group type: EXPERIMENTAL
Intervention: Ornidazole mixture‐assisted filling
Number of subjects: 124

Group type: COMPARATOR
Intervention: Pulp mummification filling
Number of subjects: 124
Study: 32730628

Group type: EXPERIMENTAL
Intervention: iv acetaminophen
Number of subjects: 195

Group type: COMPARATOR
Intervention: iv fentanyl
Number of subjects: 195
Study: 33020078

Group type: EXPERIMENTAL
Intervention: PartnerCARE online intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 60
Study: 35371287

Group type: EXPERIMENTAL
Intervention: CNHM model during bladder perfusion treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ordinary health monitoring mode
Number of subjects: 60
Study: 33112779

Group type: EXPERIMENTAL
Intervention: Handshake stewardship (HS‐ASP)
Number of subjects: 162
Study: 32380271

Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg) administered at weeks 0, 2, and 6
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (saline control) administered at weeks 0, 2, and 6
Number of subjects: 60
Study: 35786572

Group type: EXPERIMENTAL
Intervention: Mandibular overdentures retained by one implant
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Mandibular overdentures retained by two implants
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Expected burdens
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 47
Study: 34411219

Group type: EXPERIMENTAL
Intervention: Oversized drilling (OD) group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Manufacturer-recommended (MR) group
Number of subjects: 20
Study: 32456468

Group type: EXPERIMENTAL
Intervention: m-health intervention targeting physical activity and sleep
Number of subjects: 160
Study: 32713644

Group type: EXPERIMENTAL
Intervention: Left coronary artery geometry parameters
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: First centimeter angle and minimal angle in 3D
Number of subjects: 121
Study: 32916128

Group type: EXPERIMENTAL
Intervention: Nivolumab 1 mg/kg plus Ipilimumab 3 mg/kg
Number of subjects: 90
Study: 35443623

Group type: EXPERIMENTAL
Intervention: Advance care planning (ACP) intervention delivered by trained nurses, including two ACP conversations and an information brochure.
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Educational programme and topic guides for nurses.
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Nurses as ACP facilitators in home care.
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Contextual factors influencing ACP engagement.
Number of subjects: 27
Study: 32496547

Group type: EXPERIMENTAL
Intervention: Randomized splint ligation with a cleavable adapter
Number of subjects: 0
Study: 36084202

Group type: EXPERIMENTAL
Intervention: Low fluence Q-switched (LFQS) Nd: YAG 1064-nm laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional high fluence Q-switched (HFQS) Alexandrite 755-nm laser
Number of subjects: 20
Study: 33334240

Group type: EXPERIMENTAL
Intervention: Relatively Easy Success (RES) criteria
Number of subjects: 30

Group type: COMPARATOR
Intervention: Difficult Success (DS) criteria
Number of subjects: 30
Study: 36181104

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with donepezil hydrochloride orally
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham acupuncture combined with donepezil hydrochloride orally
Number of subjects: 0
Study: 33640715

Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI) with enhanced attention (EA)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI) with standard attention (SA)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: White light endoscopy (WLE) with standard attention (SA)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: White light endoscopy (WLE) with enhanced attention (EA)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Sedation
Number of subjects: 1000
Study: 32481442

Group type: EXPERIMENTAL
Intervention: Mild hypothermia
Number of subjects: 34

Group type: COMPARATOR
Intervention: Non-mild hypothermia
Number of subjects: 34
Study: 36173649

Group type: EXPERIMENTAL
Intervention: Oral octreotide capsules (OOC) at 60 mg/d, with option to titrate to 40 or 80 mg/d
Number of subjects: 40
Study: 34591812

Group type: EXPERIMENTAL
Intervention: High preprocedural anxiety (defined as a score > 40)
Number of subjects: 205
Study: 33050758

Group type: EXPERIMENTAL
Intervention: Maximum voluntary molar bite force (MVMBF)
Number of subjects: 100
Study: 35840876

Group type: EXPERIMENTAL
Intervention: Bilateral paravertebral block (PVB) with 20 mL of ropivacaine 0.375% before incision
Number of subjects: 60

Group type: COMPARATOR
Intervention: No block (Control group)
Number of subjects: 60
Study: 33336564

Group type: EXPERIMENTAL
Intervention: Intramedullary K wire fixation (IMNK)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both groups (IMNK and ORIF)
Number of subjects: 43
Study: 32205111

Group type: EXPERIMENTAL
Intervention: Ultrasound guided percutaneous puncture and closure with additional hands-on training on a pulsatile flow model
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ultrasound guided percutaneous puncture and closure without additional hands-on training
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Experienced participants (more than 20 punctures performed before the study)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Trainees
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Study group participants deploying and closing the ProGlide closure device correctly without help
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Study group participants' overall score improvement during training
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Time needed to complete the puncture and closure after training
Number of subjects: 14
Study: 36153226

Group type: EXPERIMENTAL
Intervention: Oral dydrogesterone (DYD), total daily dose 40 mg
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (VAG), total daily dose 180 mg
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Intramuscular progesterone (IMP), total daily dose 100 mg
Number of subjects: 151
Study: 32423467

Group type: EXPERIMENTAL
Intervention: Two drug regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three treatment-shortening strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjunctive ribavirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no adjunctive ribavirin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Groups with very low cure rates (<60%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Groups with moderately low cure rates (80%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall true cure rate of 95%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ribavirin comparison
Number of subjects: 0
Study: 35001215

Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (LDN) 4.5 mg orally at night, N=54
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo, N=56
Number of subjects: 110
Study: 33225374

Group type: COMPARATOR
Intervention: Exercise advice and motivational support (Control group)
Number of subjects: 15
Study: 32640411

Group type: EXPERIMENTAL
Intervention: Dissociative seizures-specific cognitive behavioral therapy (CBT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Standardized Medical Care (SMC)
Number of subjects: 30
Study: 32084442

Group type: EXPERIMENTAL
Intervention: Ultrasound of the calcaneus measuring speed of sound (SOS), broadband ultrasound attenuation (BUA), and bone quality index (BQI)
Number of subjects: 1322
Study: 32494883

Group type: EXPERIMENTAL
Intervention: Robot-assisted thoracoscopic esophagectomy
Number of subjects: 20
Study: 35798516

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 531

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 531
Study: 33927413

Group type: EXPERIMENTAL
Intervention: BPN14770 25 mg twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32560681

Group type: EXPERIMENTAL
Intervention: Independent Housing and Support (IHS)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Residential Care Settings/Treatment as Usual (RCS/TAU)
Number of subjects: 168
Study: 33452561

Group type: COMPARATOR
Intervention: Normal prophylactic antibiotic treatment given only on the day of surgery (Group A)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Prolonged antibiotic treatment given for 1 week after surgery (Group B)
Number of subjects: 72
Study: 32899959

Group type: EXPERIMENTAL
Intervention: PRP therapy
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Combination of PRP and minoxidil
Number of subjects: 69

Group type: COMPARATOR
Intervention: Minoxidil
Number of subjects: 69
Study: 35492306

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 100
Study: 35010953

Group type: EXPERIMENTAL
Intervention: American ginseng (AG) extract (1.6 g/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 12
Study: 35673488

Group type: EXPERIMENTAL
Intervention: 220 mg/d ZnSO4 for 8 weeks
Number of subjects: 46
Study: 32882310

Group type: EXPERIMENTAL
Intervention: Avacincaptad pegol 2 mg
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Avacincaptad pegol 4 mg
Number of subjects: 286

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 286
Study: 33446045

Group type: EXPERIMENTAL
Intervention: Teacher-based child sexual abuse prevention program (5-week program with modules on emotional awareness, good touch-bad touch, and body safety rules)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Wait-list comparison group (no intervention)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 290

Group type: COMPARATOR
Intervention: Wait-list comparison group
Number of subjects: 290
Study: 35819285

Group type: EXPERIMENTAL
Intervention: Toric Orthokeratology (TOK)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Soft Toric Multifocal (STM)
Number of subjects: 30
Study: 33208345

Group type: EXPERIMENTAL
Intervention: Tocilizumab (6 monthly infusions)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 32787978

Group type: EXPERIMENTAL
Intervention: Enhanced Primary Healthcare (EnPHC) intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 40
Study: 35554892

Group type: EXPERIMENTAL
Intervention: Maternal Kangaroo Care (M-KC)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Paternal Kangaroo Care (F-KC)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Incubator (before KC)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Incubator (after KC)
Number of subjects: 35
Study: 35208573

Group type: COMPARATOR
Intervention: Single-leg hopping in long-term treated Wilson patients
Number of subjects: 29
Study: 34368890

Group type: EXPERIMENTAL
Intervention: CAPOX (capecitabine plus oxaliplatin) plus bevacizumab
Number of subjects: 47
Study: 33115534

Group type: EXPERIMENTAL
Intervention: Genetic predisposition to longer telomere length (measured by polygenic score)
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Genetic predisposition to longer telomere length
Number of subjects: 339
Study: 35909321

Group type: EXPERIMENTAL
Intervention: Medicines at Transitions of care Intervention (MaTI) including a patient-held My Medicines Toolkit, enhanced communication with community pharmacists, and increased engagement of community pharmacists post-discharge.
Number of subjects: 0
Study: 34166370

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 750 mg twice/day (n = 119)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Azathioprine (AZA) 75 to 125 mg/day (n = 114)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Combined events
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: 3-year glomerular filtration rate (GFR)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 233
Study: 32532262

Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT) during early pulmonary rehabilitation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-flow nasal therapy (HFNT)
Number of subjects: 0
Study: 35033133

Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM)
Number of subjects: 210

Group type: COMPARATOR
Intervention: No continuous passive motion (no-CPM)
Number of subjects: 210
Study: 35487978

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) using PREVENA dressings applied for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional dressings applied immediately upon completion of surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional dressings
Number of subjects: 0
Study: 32276301

Group type: EXPERIMENTAL
Intervention: Blue-blocking glasses (BB)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (clear glasses)
Number of subjects: 43
Study: 34894361

Group type: EXPERIMENTAL
Intervention: Survivorship care plans (SCPs)
Number of subjects: 74
Study: 33155862

Group type: EXPERIMENTAL
Intervention: Communication skills training intervention (INT) consisting of an interactive training session and four joint visits with communication coaches
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 22
Study: 32051084

Group type: EXPERIMENTAL
Intervention: Early Start Denver Model (ESDM) intensive training
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Parental training combined with ESDM intensive training
Number of subjects: 70

Group type: COMPARATOR
Intervention: Parental training
Number of subjects: 70
Study: 34724172

Group type: EXPERIMENTAL
Intervention: 10 µg bimatoprost implant
Number of subjects: 528

Group type: EXPERIMENTAL
Intervention: 15 µg bimatoprost implant
Number of subjects: 528

Group type: COMPARATOR
Intervention: Topical timolol maleate 0.5% (Control)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Topical timolol (Control)
Number of subjects: 528
Study: 32234665

Group type: EXPERIMENTAL
Intervention: Trametinib daily (arm 1)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Fluoropyrimidine therapy (infusional 5‐fluorouracil or oral capecitabine, arm 2)
Number of subjects: 44
Study: 34716571

Group type: EXPERIMENTAL
Intervention: Gentamycin and ampicillin, injected intravenously for 4 days.
Number of subjects: 71
Study: 34199802

Group type: EXPERIMENTAL
Intervention: Adjuvant vitamin D3 (100,000 IU every 50 days)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 34392162

Group type: EXPERIMENTAL
Intervention: Active group (AG) receiving repetitive Transcranial Magnetic Stimulation (rTMS) during cognitive stimulation sessions
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham group (SG) receiving sham stimulation during cognitive stimulation sessions
Number of subjects: 22
Study: 32928218

Group type: EXPERIMENTAL
Intervention: Swedish version of the EHP-30
Number of subjects: 211
Study: 33940204

Group type: EXPERIMENTAL
Intervention: Maternal stress (toxic stress)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Support from family, infants, health care providers, social service programs, and community organizations
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Maternal stress responses
Number of subjects: 32
Study: 34444492

Group type: EXPERIMENTAL
Intervention: FL + FD + PG
Number of subjects: 538
Study: 32109935

Group type: EXPERIMENTAL
Intervention: Remitted psychotic depression patients
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Insular‐limbic network
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Cross-sectional depression and severity scores
Number of subjects: 245
Study: 36326594

Group type: EXPERIMENTAL
Intervention: Pyramidal + Plyometric Training (PYR + PLY)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Polarized + Plyometric Training (POL + PLY)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pyramidal (PYR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Polarized (POL)
Number of subjects: 60
Study: 32921595

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (including atherectomy, drug coated balloons, stenting)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Orbital atherectomy
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Jetstream
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: SilverHawk/TurboHawk
Number of subjects: 89
Study: 32632732

Group type: EXPERIMENTAL
Intervention: Adapted ERAS
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 35
Study: 33236669

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the Health Belief Model
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 32969628

Group type: EXPERIMENTAL
Intervention: Functional brioche containing wheat bran and bergamot fiber
Number of subjects: 11

Group type: COMPARATOR
Intervention: Classic brioche
Number of subjects: 11
Study: 34870331

Group type: EXPERIMENTAL
Intervention: Air polishing
Number of subjects: 44

Group type: COMPARATOR
Intervention: Full-mouth sub- and supragingival instrumentation using scalers and curets
Number of subjects: 44
Study: 33914047

Group type: EXPERIMENTAL
Intervention: Sustained-release verapamil plus trandolapril
Number of subjects: 16688
Study: 33274552

Group type: EXPERIMENTAL
Intervention: Dietary fish oil supplementation in mice; no specific dosage or duration mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary fish oil supplementation in humans with overweight or obesity; no specific dosage or duration mentioned.
Number of subjects: 0
Study: 32279446

Group type: EXPERIMENTAL
Intervention: Ramucirumab
Number of subjects: 542

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 542
Study: 36189668

Group type: EXPERIMENTAL
Intervention: Pupillometry-controlled administration of sufentanil
Number of subjects: 61

Group type: COMPARATOR
Intervention: Free-choice administration of sufentanil by anesthesiologists
Number of subjects: 61
Study: 33602798

Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Indirect Video Laryngoscopy (IVL)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Augmented Reality-Assisted Video Laryngoscopy (ARVL)
Number of subjects: 45
Study: 33271852

Group type: EXPERIMENTAL
Intervention: Cyberbullying involvement (victim or perpetrator)
Number of subjects: 4978

Group type: EXPERIMENTAL
Intervention: Family cohesion
Number of subjects: 4978

Group type: EXPERIMENTAL
Intervention: School cohesion
Number of subjects: 4978

Group type: EXPERIMENTAL
Intervention: Interactions in regression models
Number of subjects: 4978

Group type: EXPERIMENTAL
Intervention: Gender (female students)
Number of subjects: 4978

Group type: EXPERIMENTAL
Intervention: Grade level (higher grade)
Number of subjects: 4978

Group type: EXPERIMENTAL
Intervention: Academic performance (worse performance)
Number of subjects: 4978
Study: 35475852

Group type: EXPERIMENTAL
Intervention: 5% fluorouracil
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: 5% imiquimod
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: methylaminolevulinate photodynamic therapy
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: 0.015% ingenol mebutate gel
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: Severe AK (Olsen grade III)
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: Severe AK (Olsen grade III) with additional treatment
Number of subjects: 624
Study: 32227613

Group type: EXPERIMENTAL
Intervention: Semaglutide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36107583

Group type: EXPERIMENTAL
Intervention: Mobile Mindfulness Training (MMT) for 4 weeks
Number of subjects: 45

Group type: COMPARATOR
Intervention: Wait-list Control (WLC) group, no intervention
Number of subjects: 45
Study: 34154426

Group type: EXPERIMENTAL
Intervention: bundle of interventions to treat postpartum haemorrhage
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: monitor sample size assumptions
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: monitoring for adherence
Number of subjects: 80
Study: 33351387

Group type: EXPERIMENTAL
Intervention: Citrulline supplementation
Number of subjects: 16

Group type: COMPARATOR
Intervention: No citrulline supplementation (Control group)
Number of subjects: 16
Study: 35727586

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg on day 1 followed by 90 mg twice daily on days 2-90) plus aspirin (75-300 mg on day 1 followed by 75 mg daily for 21 days)
Number of subjects: 6412

Group type: COMPARATOR
Intervention: Clopidogrel (300 mg on day 1 followed by 75 mg daily on days 2-90) plus aspirin (75-300 mg on day 1 followed by 75 mg daily for 21 days)
Number of subjects: 6412

Group type: EXPERIMENTAL
Intervention: Ticagrelor and aspirin
Number of subjects: 6412
Study: 34531495

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy
Number of subjects: 84
Study: 34230018

Group type: EXPERIMENTAL
Intervention: iCBT: GROw
Number of subjects: 48

Group type: COMPARATOR
Intervention: face‐to‐face CBT treatment
Number of subjects: 48
Study: 32674009

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) with usual care (exercise and orthotic support)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care (exercise and orthotic support)
Number of subjects: 44
Study: 33641414

Group type: EXPERIMENTAL
Intervention: Direct Superior Approach (DSA)
Number of subjects: 100